These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 35116551)
1. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma. Xu T; Dai T; Zeng P; Guo Y; He K Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
3. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma. Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
5. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer. Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797 [TBL] [Abstract][Full Text] [Related]
6. Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing. Wang X; Peng W; Zhao Y; Sha J; Li N; Huang S; Wang H Front Oncol; 2024; 14():1370801. PubMed ID: 38903709 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes. Peng Z; Liu XY; Cheng Z; Kai W; Song Z Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782 [TBL] [Abstract][Full Text] [Related]
8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y Front Immunol; 2023; 14():1199040. PubMed ID: 37313409 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer. Du H; Pang S; Li Y; Zhu L; Hang J; Chen L J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327 [TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma. Xiong K; Tao Z; Zhang Z; Wang J; Zhang P Front Bioeng Biotechnol; 2022; 10():850669. PubMed ID: 35497331 [TBL] [Abstract][Full Text] [Related]
11. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Ma C; Luo H Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781 [TBL] [Abstract][Full Text] [Related]
12. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma. Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188 [No Abstract] [Full Text] [Related]
13. M Wang R; Cheng X; Chi D; Liu S; Li Q; Chen B; Xi M Discov Oncol; 2023 Jun; 14(1):99. PubMed ID: 37314494 [TBL] [Abstract][Full Text] [Related]
14. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma. Cheng J; Chen F; Cheng Y Cells; 2022 Oct; 11(21):. PubMed ID: 36359828 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
16. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma. Zhang D; Zhao F; Li J; Qin X; Li S; Niu R Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524 [TBL] [Abstract][Full Text] [Related]
17. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC). Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821 [TBL] [Abstract][Full Text] [Related]
18. A Novel Kong J; Liu Y; Wang J; Qian M; Sun W; Xing L Clin Med Insights Oncol; 2024; 18():11795549241275666. PubMed ID: 39281690 [TBL] [Abstract][Full Text] [Related]
19. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q Front Genet; 2022; 13():851373. PubMed ID: 35401707 [No Abstract] [Full Text] [Related]
20. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]